RxDoctor Payments Data

Amy Ethridge, NP

Nurse Practitioner · Vincennes, INNPI 1578022109

Payments from drug & device makers

$2,275in general payments, 2019–2025

Across 96 payments — averaging $23.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$381
  • Johnson & Johnson$184
  • AbbVie$167
  • Tempus AI, Inc$158
  • Merck$151
  • Incyte Corporation$137
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$1,97687%
  • Education$29913%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,275 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$60,308
Medicare patients
275
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide18$345,070
Lenalidomide23$333,576
ErleadaApalutamide17$241,571
IbrancePalbociclib11$175,829
KisqaliRibociclib Succinate11$145,744
XareltoRivaroxaban23$15,723
EliquisApixaban21$14,624
Anastrozole214$2,481
Letrozole36$1,261
Exemestane11$830
Prochlorperazine Maleate23$636
Ondansetron Hcl21$497
Hydroxyurea21$482
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$386
Potassium Chloride31$285

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$15$345,07018 claims
Johnson & JohnsonErleada, Xarelto$184$257,29440 claims
PfizerIbrance, Eliquis$90$190,45332 claims
NovartisKisqali$381$145,74411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Vincennes

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →